Biofil Chemicals and Pharmaceuticals Limited has reported a significant turnaround in profitability for the quarter ended September 30, 2025, despite a notable decline in revenue. The company's board approved the unaudited financial results for Q2 FY2026 on November 13, 2025.

Financial Highlights

• Revenue: The company's revenue from operations decreased to Rs 199.73 crore in Q2 FY2026, down from Rs 334.02 crore in the corresponding quarter of the previous year, marking a 40.20% year-on-year decline.

• Profitability: Despite the revenue drop, Biofil Chemicals posted a net profit of Rs 241.10 crore for the quarter, compared to a loss of Rs 244.19 crore in the same period last year, representing a remarkable turnaround in the company's bottom line.

• Earnings Per Share (EPS): The basic and diluted EPS for the quarter stood at Rs 1.48, a significant improvement from Rs 0.01 in Q2 FY2025.

Segment Performance

The company operates in two primary segments:

1. Pharma Products
2. Chemicals Division

However, specific segment-wise revenue figures were not provided in the available data.

Balance Sheet Overview

As of September 30, 2025:

Conclusion

Biofil Chemicals and Pharmaceuticals Limited has demonstrated resilience in its financial performance for Q2 FY2026. The company's ability to generate substantial profits despite a considerable drop in revenue suggests effective cost management or potentially diversified income streams. Investors and analysts may seek further clarification on the factors contributing to this performance during the next earnings call or investor presentation.

Note: All figures are in Indian Rupees (INR) and have been reported as per the Indian Accounting Standards (Ind-AS).

Biofil Chemicals and Pharmaceuticals Limited has received strong shareholder approval for the sale of leasehold rights of a significant portion of its industrial land in Pithampur, Madhya Pradesh. The special resolution, passed through a postal ballot, marks a strategic move for the company.

Key Highlights

• Land Details: The resolution pertains to the sale, transfer, or disposal of leasehold rights for a vacant portion of industrial land measuring 80,156 square meters.
• Location: The land is situated at Plot No. 8, Sector-3, Kheda Industrial Estate, Pithampur, District Dhar, Madhya Pradesh.
• Voting Results: An overwhelming 99.93% of votes were cast in favor of the resolution, with 8,974,224 votes supporting and only 6,503 votes against.
• Voting Process: The e-voting process was overseen by L.N. Joshi as the scrutinizer.
• Shareholder Participation: Out of 25,845 total shareholders, postal ballot notices were sent to 23,017 members via email, representing 89.06% of the total shareholder base.

Voting Details

Implications and Next Steps

The strong shareholder support for this resolution allows Biofil Chemicals and Pharmaceuticals Limited to proceed with the disposal of leasehold rights for the vacant industrial land. This move could potentially unlock value from non-core assets and provide the company with additional financial flexibility.

The company's management will now be able to execute the sale or transfer of the leasehold rights as per the terms approved by the shareholders. This decision may have significant implications for Biofil Chemicals' asset portfolio and future strategic plans.

Investors and stakeholders will likely be watching closely to see how the company utilizes the proceeds from this potential sale and its impact on Biofil Chemicals' overall financial position and operational strategy.

The successful passage of this resolution demonstrates strong alignment between the company's management and its shareholders on this strategic decision. It also reflects the company's commitment to transparent corporate governance practices, as evidenced by the detailed voting process and results disclosure.